BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17400356)

  • 1. Diverse functions of RNase L and implications in pathology.
    Bisbal C; Silverman RH
    Biochimie; 2007; 89(6-7):789-98. PubMed ID: 17400356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
    Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase L: its biological roles and regulation.
    Liang SL; Quirk D; Zhou A
    IUBMB Life; 2006 Sep; 58(9):508-14. PubMed ID: 17002978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RNase L, a crucial mediator of innate immunity and other cell functions].
    Bisbal C; Salehzada T
    Med Sci (Paris); 2008 Oct; 24(10):859-64. PubMed ID: 18950583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for RNase L in prostate cancer biology.
    Silverman RH
    Biochemistry; 2003 Feb; 42(7):1805-12. PubMed ID: 12590567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
    Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
    Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.
    Asthana A; Gaughan C; Dong B; Weiss SR; Silverman RH
    mBio; 2021 Aug; 12(4):e0178121. PubMed ID: 34372695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
    Malathi K; Dong B; Gale M; Silverman RH
    Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scientific journey through the 2-5A/RNase L system.
    Silverman RH
    Cytokine Growth Factor Rev; 2007; 18(5-6):381-8. PubMed ID: 17681844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action.
    Silverman RH
    J Interferon Res; 1994 Jun; 14(3):101-4. PubMed ID: 7523539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
    Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
    J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome.
    Nijs J; De Meirleir K
    In Vivo; 2005; 19(6):1013-21. PubMed ID: 16277015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of RNase L with a Ras GTPase-activating-like protein IQGAP1 in mediating the apoptosis of a human cancer cell-line.
    Sato A; Naito T; Hiramoto A; Goda K; Omi T; Kitade Y; Sasaki T; Matsuda A; Fukushima M; Wataya Y; Kim HS
    FEBS J; 2010 Nov; 277(21):4464-73. PubMed ID: 20875083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNase L is a negative regulator of cell migration.
    Banerjee S; Li G; Li Y; Gaughan C; Baskar D; Parker Y; Lindner DJ; Weiss SR; Silverman RH
    Oncotarget; 2015 Dec; 6(42):44360-72. PubMed ID: 26517238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule activators of RNase L with broad-spectrum antiviral activity.
    Thakur CS; Jha BK; Dong B; Das Gupta J; Silverman KM; Mao H; Sawai H; Nakamura AO; Banerjee AK; Gudkov A; Silverman RH
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9585-90. PubMed ID: 17535916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
    Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune messenger 2-5A tethers human RNase L into active high-order complexes.
    Han Y; Whitney G; Donovan J; Korennykh A
    Cell Rep; 2012 Oct; 2(4):902-13. PubMed ID: 23084743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into RNase L through use of an MDMX-derived multi-functional protein domain.
    Garvie CW; Vasanthavada K; Xiang Q
    Biochim Biophys Acta; 2013 Aug; 1834(8):1562-71. PubMed ID: 23608948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interferon-inducible recombinant human RNase L causes RNA degradation and inhibition of cell growth in Escherichia coli.
    Pandey M; Rath PC
    Biochem Biophys Res Commun; 2004 Apr; 317(2):586-97. PubMed ID: 15063798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
    Nakanishi M; Goto Y; Kitade Y
    Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.